GlassScriptPhysician profile
Roger Matthews
NPI 1104820570
$1,403.51
in general payments reported to CMS, 2019-2025
29 companies · $166 in 2025
The $166 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $521 · 2020: $81.11 · 2021: $50.57 · 2022: $468 · 2023: $15.91 · 2024: $101 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $282.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $213.33 | 2022-2024 | |
| Janssen Pharmaceuticals, INC | $212.75 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $149.08 | 2019-2025 | Airsupra |
| Grifols USA, LLC | $91.84 | 2019-2022 | |
| Pfizer INC. | $67.11 | 2019-2024 | |
| Hologic Sales and Service, LLC | $56.22 | 2019-2025 | Thinprep 2000 Processor, Aptima |
| Boston Scientific Corporation | $49.11 | 2019-2022 | |
| Glaxosmithkline, LLC. | $44.56 | 2019-2023 | Arexvy, Shingrix |
| Amgen INC. | $43.33 | 2022-2024 | Repatha |
| Allergan, INC. | $43.16 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $42.67 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $39.43 | 2022 | |
| Novo Nordisk INC | $38.09 | 2022 | |
| Astellas Pharma US INC | $31.41 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $29.79 | 2019 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $27.41 | 2022 | |
| Sanofi-Aventis U.S. LLC | $26.26 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.11 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $22.98 | 2019 | |
| Exact Sciences Corporation | $19.40 | 2024 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $17.43 | 2021 | |
| Eisai INC. | $16.46 | 2022 | |
| Hikma Pharmaceuticals USA | $15.50 | 2019 | |
| Sunovion Pharmaceuticals INC. | $15.28 | 2022 | |
| Tactile Systems Technology INC | $15.15 | 2024 | Entre Plus, Flexitouch Plus |
| Lilly USA, LLC | $15.04 | 2022 | |
| Novartis Pharmaceuticals Corporation | $14.09 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.81 | 2019 | |
| Quidel Corporation | $9.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roger Matthews listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.